Thought Leadership Cell & Gene Manufacturing & Production

Centralised Off-The-Shelf Cell Therapies: Interview with Volker Huppert, Glycostem

On-Demand
October 9, 2025
|
11:00 UK Time
|
Event lasts 17m
Volker Huppert

Volker Huppert

Chief Development Officer

Glycostem

Format: 17 Minute Interview

Related posts

Interview with Alexander Eggermont

Alexander Eggermont Utrecht University
Cell & Gene
Feb, 2026
Delivering Next Generation Regenerative Medicine

Delivering Next Generation Regenerative Medicine

Molly Stevens University of Oxford
Roger Barker University of Cambridge
Andrea Serio Francis Crick Institute
George Malliaras University of Cambridge
Cell & Gene
Jan, 2026
Animal Free 3D Cell Culture and Organoid Growth: Interview with Aline Miller, University of Manchester

Animal Free 3D Cell Culture and Organoid Growth: Interview with Aline Miller, University of Manchester

Aline Miller University of Manchester
Cell & Gene
Nov, 2025
Developing CAR T for Solid Tumours: Interview with John Bridgeman, ImmunoKey

Developing CAR T for Solid Tumours: Interview with John Bridgeman, ImmunoKey

John Bridgeman ImmunoKey
Cell & Gene
Nov, 2025
Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms

Maryna Panamarova Wellcome Sanger Institute
Aline Miller University of Manchester
Vasiliki Kalodimou European University-Cyprus – Frankfurt Branch
Andy Wiranata Wijaya Nestlé
Cell & Gene
Nov, 2025
Upcoming events
24
Mar
NextGen Biomed 2026

In-Person

NextGen Biomed has evolved over 18 years, from six individual events and communities into a unified platform designed to address the need for interdisciplinary collaboration, year-round engagement, and streamlined innovation and best practice sharing.

12
May
Computational Antibody Discovery

Online

Explore cutting-edge advancements in computational antibody discovery platforms, featuring real-world case studies on AI/ML in antibody engineering.

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.